BUZZ-Nuvo Research Inc: Top loser on Toronto Stock Exchange

Fri Jan 30, 2015 10:10am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Specialty pharmaceutical company's shares down 39.8 pct at C$5.33; stock top percentage loser on the Toronto Stock Exchange

** Says experimental drug to treat allergic rhinitis fails to meet primary goal in mid-stage study

** Allergic rhinitis is a common condition characterized by nasal symptoms triggered by response to one or more allergens such as pollens and house dust mites

** Up to Thursday's close, stock had nearly tripled in the past 12 months